Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × etaracizumab × Clear all

NCT00072930 2008-01-15

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms